Analyst Ratings for Sucampo Pharmaceuticals Inc. Cl A (SCMP)

Updated: 2017-07-28

An average rating of Buy has been given to Sucampo Pharmaceuticals Inc. Cl A (NASDAQ:SCMP) by analysts covering the stock. SCMP had previously received a consensus rating of Buy a month ago.

4 analysts declared SCMP a buy, 0 issued an overweight rating, 1 gave a hold rating, 0 issued an underweight rating, and 0 issued a sell rating. Compared to three months ago, there has been an increase of 0 in the number of analysts with a positive outlook on the stock. Meanwhile, the number of analysts pessimistic about the company has increased by 0.

Several price targets were given for SCMP by the analysts covering the stock. The maximum price target given was 29.5, implying a possible profit of 171.89 percent. The most pessimistic price target was 11, implying a possible loss of 1.38 percent. It is crucial to not blindly accept any price targets or stock ratings, because many analysts have it in their best interest to give positive coverage of certain stocks.

Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of 0 percent. The average change in earnings estimates over the last 90 days is -8.07 percent. On the other hand, earnings estimates for the fiscal year have been revised upwards by 0 percent, as compared to a month ago. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes -12.21 percent.

People are often interested in whether analysts were united in the direction of their revisions. 0 analysts made positive revisions to their quarterly estimates over the past month, which can be compared to the 0 analysts that decreased their estimates. Also over the last month, 0 analysts increased their estimates for the FY earnings, compared to 0 analysts that revised their FY estimates downwards.

The growth rate of SCMP's earnings is estimated by analysts to be 66.42 percent. Another measure frequently examined by investors is the PEG ratio. Smaller PEG ratios are desirable, as that can indicate whether the high price level of a stock is warranted by high growth. Many investors consider PEG ratios between 0 and 1 as preferrable, though it could be better to see where the ratio stands relative to peers in the industry. The PEG ratio of SCMP is 0.27.

SCMP has a 52-week high of 17.55 and a 52-week low of 9.30. Currently the stock is 16.67 percent higher than its low, and below the high by 38.18 percent. SCMP has a price/earnings ratio of 17.79. Investors typically compare the P/E ratio to a company's peers in the industry. The SCMP value stock report compares SCMP to some of its peers using value stock charts. The market cap of SCMP is $0.50182 billion. SCMP's next earnings release will be on 0000-00-00, which is days away.